SCHEMBL31452285

SCHEMBL31452285

COc1cccc2c1C(=O)N[C@H]1[C@H](O)[C@H](O)[C@@H](O)C[C@H]21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLL Q9UGP5 1/20 0.44
HTR2A P28223 4/20 0.37
HTR2C P28335 4/20 0.37
HTR2B P41595 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 4/20 0.35
GAA P10253 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
POLB P06746 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MASP2 O00187 1/20 0.35
GAPDH P04406 1/20 0.35
HSPA1A P0DMV8 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
HSPA8 P11142 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31452289 0.82 HTR2A (0.35) HTR2AHTR2CHTR2BL3MBTL1KDM4E
SCHEMBL31452409 0.77 POLL (0.37) POLLHTR2AHTR2CHTR2BL3MBTL1
SCHEMBL19249656 0.75 POLL (0.51) POLLHTR2AHTR2CHTR2BL3MBTL1
SCHEMBL31452313 0.72 METAP1 (0.36) KDM4EGAACYP3A4ALDH1A1HSPA1A
SCHEMBL3833035 0.72 POLL (0.51) POLLHTR2AHTR2CHTR2BL3MBTL1
SCHEMBL11352016 0.67 KDM4E (0.47) POLLL3MBTL1KDM4EGAACYP3A4
SCHEMBL11363652 0.66 CYP1A2 (0.48) POLLHTR2AHTR2CHTR2BKDM4E
SCHEMBL31452272 0.66 DYRK1A (0.38) HTR2AHTR2CHTR2BGAAALDH1A1
SCHEMBL11362493 0.66 POLL (0.42) POLLHTR2AHTR2CHTR2BL3MBTL1
SCHEMBL16591167 0.63 HTR2C (0.57) POLLHTR2AHTR2CHTR2BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066306-A1 COMPOUNDS FOR TREATING MICROBIAL INFECTIONS, METHODS OF MAKING AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2025-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066306-A1 COMPOUNDS FOR TREATING MICROBIAL INFECTIONS, METHODS OF MAKING AND USES THEREOF ATF4, ATF1, CGAS POLL 4023/4885HTR2A 3864/4885HTR2C 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.